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Abstract. Sixteen Leishmania stocks, 15 isolated from patients with cutaneous (CL), mucocutaneous (MCL), or
recurrent cutaneous leishmaniasis, plus one from a dog with CL in Salta and Corrientes Provinces, Argentina, were
studied by multilocus enzyme electrophoresis. Thirteen of the stocks from humans were grouped in two zymodemes;
nine termed as KMS 1, four as KMS 2, and assigned to Leishmania (Viannia) braziliensis. Two additional stocks from
CL cases expressed a KMS 4 enzyme profile, corresponding to L. (V.) guyanensis. Although the parasites from the dog
were also assigned to L. (V.) braziliensis, its zymodeme, KMS 3, was not expressed in any of the current human isolates.
The characterization of Leishmania from a dog was done for the first time in Argentina. The importance of the
intraspecific polymorphism in the induction of clinical forms and in the host-reservoir concept is briefly discussed, based
on the zymodeme data of isolates from humans and dogs. The presence of L. (V.) guyanensis was confirmed in the
country.
INTRODUCTION
American tegumentary leishmaniasis (ATL) is a group of
zoonotic diseases widespread in 22 countries from Texas
(USA) to northern Argentina. It is caused by flagellar proto-
zoa belonging to the genus Leishmania1 in which a tremen-
dous diversity or polymorphism has been found.2 The dis-
eases caused by different species are distinct in their clinical
manifestations, drug responses, and prognosis. Therefore, it is
necessary to characterize and identify specifically the para-
sites obtained in each endemic area where a survey is taken.3
For this purpose, multilocus enzyme electrophoresis (MLEE)
analysis has been recommended by the World Health Orga-
nization (WHO).4
In northern Argentina, some areas have been reported to
be endemic for human and canine leishmaniasis. However,
little is known about the causative agents, Leishmania spp.,
and the transmission cycles implicated there. Salta and Cor-
rientes Provinces are endemic areas, where most of the clini-
cal forms of human ATL showed single and multiple cutane-
ous (CL), mucocutaneous (MCL), or mucosal lesions (Borda
CE and others, unpublished data).5,6 Vegetant nonulcerated
lesions with metastasis to the lymph nodes and viscus (spleen)
have also been described.7 As to the causative parasites, it
was found that L. (Viannia) braziliensis was predominant in
Salta Province, followed by L. (Leishmania) amazonensis,
and L. (V.) guyanensis, though relatively few isolates were
specifically characterized to date.2,8,9
Previously, we studied the clinical, parasitological, and se-
rological characteristics of canine tegumentary leishmaniasis
in Salta Province. Several observations from these works sug-
gested that dogs might be considered as a susceptible host
without having a principal role in the spread of the dis-
ease.10,11 However, any Leishmania stock was not isolated
from dogs in this area before.
This paper reports the species attribution and the exami-
nations of the relationship between Leishmania isolates from
different clinical forms of human and canine ATL in northern
Argentina, based on MLEE data; the first description of ca-
nine Leishmania isolate in the country is herein provided. The
relevance of the intraspecific polymorphism to the induction
of different clinical forms, as well as its incidence in the host-
reservoir concept, is briefly discussed.
MATERIALS AND METHODS
Parasites and study area. Sixteen stocks of Leishmania
were included in this study. Fourteen of them, from 11 hu-
mans, and one stock from a dog were isolated in Salta Prov-
ince, northwest Argentina. The remaining one was obtained
from a patient in Corrientes Province, located in the northeast
of Argentina. Their denomination, the clinical data of the
host, and a description of the geographical origin are shown in
Table 1 and Figure 1. The samples were taken from patients
who were accessed in the four institutions, viz., the Instituto
de Investigaciones en Enfermedades Tropicales, Subsede
Orán, Universidad Nacional de Salta; the Dermatology Ward
of Hospital del Milagro; the Dermatology and Otorhinolar-
yngology Wards of Hospital San Bernardo of Salta City; and
Centro Nacional de Parasitología y Enfermedades Tropicales,
Universidad Nacional del Nordeste, Corrientes City. A part
of the current isolates was obtained from humans and canine
cases during house-to-house visits.
All the referred patients, from whom Leishmania parasites
were isolated from their lesions, were systemically treated for
25–30 days with 10–20 mg d−1 kg body wt−1 of pentavalent
antimony for each cycle. In the cases of the incomplete clini-
cal cure of lesion, another cycle of treatment or amphotericin
B treatment was given.4 The clinical controls and treatment
protocols were exclusively conduced for local physicians. The
patients voluntarily consented to participate in this study, and
the Bioethical Commission of Health Ministry of Salta Prov-
ince approved the procedures.
Six WHO reference strains were included; L. (V.) brazilien-
sis, MHOM/BR/75/M2904; L. (V.) panamensis, MHOM/PA/
71/LS94; L. (V.) guyanensis, MHOM/BR/75/M4147; L. (L.)
amazonensis, MHOM/BR/73/M2269; L. (L.) mexicana,
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MNYC/BZ/62/M379; and L. (L.) chagasi (syn. Infantum),
MHOM/BR/74/M2682.
Isolation and mass cultivation. Thirteen stocks were ob-
tained by aspiration of the CL or MCL lesion edges of hu-
mans or dogs, using a syringe with 0.5 mL of sterile proline
balanced salts solution (PBSS) containing 100 U/mL penicil-
lin and 50 g/mL streptomycin (P E). The material aspirated
was inoculated into Difco blood agar (USMARU) medium
containing 20% of defibrinated rabbit blood.12,13 One millili-
ter of PBSS with P E was added after 4 days of incubation at
23°C. A final volume of liquid phase of 2 mL was reached
after 4 days more. One stock (JDM1) was obtained by an
inoculation of the aspirated material into a footpad of a
golden hamster (Mesocricetus auratus). Two months after the
inoculation, the footpad tissue was aseptically removed, ho-
mogenized, and inoculated into five culture tubes containing
2 mL of sterile liver infusion tryptose medium supplemented
with P E and 20% heat-inactivated fetal bovine serum
(hiFBS).12 The remaining two stocks (AZ3, LBC1) were iso-
lated by skin biopsy of the cutaneous lesion edges and trans-
ferred to Novy-Nicolle-Mac Neal (NNN) medium.
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FIGURE 1. Map of the north of Salta Province, Argentina, show-
ing phytogeographical locations of the zymodemes. Leishmania (Vi-
annia) braziliensis: KMS 1,  KMS 2, and  KMS 3. L. (V.) gu-
yanensis: KMS 4. Selva y Bosque Montano: Subtropical humid
forest within 900–3000 m above sea level (m.a.s.l.). Annual precipi-
tations (ann. prec.): 700–2000 mm. Annual mean temperature
(AMT): 20°C. Selva de Transición: Subtropical humid forest
within 340–700 m.a.s.l. Ann. prec.: 700–1070 mm. AMT: 20°C (Co-
mité MAB Argentino, unpublished data). Chaco Occidental: Xe-
rophytic lowland plain and semiarid climate within 300 m.a.s.l. (max).
Ann. prec.: 550 mm. AMT: 23°C (Gasparri I and others, unpublished
data).
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The cultures were examined regularly from the 4th to 30th
day of inoculation. When promastigotes were not found, the
culture was gently centrifuged and the used USMARU me-
dium was replaced by a fresh one after washing the pellet
twice in 5 mL of PBSS.
For mass cultivation, 1 mL of promastigotes-culture in
logarithmic phase was transferred to 6 mL RPMI 1640 me-
dium supplemented with 10% of hiFBS. The culture volume
was duplicated once every 2 days to reach a volume of 70 mL
and incubated for a maximum of 12 days. The promastigotes
were harvested by centrifugation at 10,000 rpm for 15 minutes
at 4°C, after washing (2,500 rpm, 20 minutes) 3 times with
sterile 0.85% NaCl solution. The pellets were stored in a deep
freezer (−80°C) until use.
Sample preparation. The soluble enzyme extracts were ob-
tained by lysis of the pellets in a double volume of stabilizer
solution containing 2 mM dithiotreitol, 2 mM -aminocaproic
acid, and 2 mM EDTA. After 3 cycles of freezing and thaw-
ing, the supernatants obtained by centrifugation at 27,000 rpm
at 4°C were aliquoted and stored at −80°C.12
Enzyme electrophoresis. Electrophoresis and staining pro-
cedures were performed on cellulose acetate support (Sebia-
gel; Moulineux, France) following the methods described by
Kreutzer and Christensen and by Evans, with slight modifi-
cations.12,14 Pictures of gels were taken with a Kodak EDAS
290 digital camera. Each enzyme extract was analyzed at least
twice by 11 enzyme systems for 12 putative enzymatic loci:
alanine aminotransferase (E.C.2.6.1.2, ALAT), aspartate
aminotransferase (E.C.2.6.1.1, ASAT), glucose-6-phosphate
dehydrogenase (E.C.1.1.1.49, G6PDH), 6-phosphogluconate
dehydrogenase (E.C.1.1.1.44, 6GPDH), glucose-phosphate
isomerase (E.C.5.3.1.9, GPI), malate dehydrogenase
(E.C.1.1.1.37, MDH), malic enzyme (E.C.1.1.1.40, ME), man-
nose-phosphate isomerase (E.C.5.3.1.8, MPI), nucleoside
hydrolase (inosine) (E.C.2.4.2, NHi1 and NHi2), phospho-
glucomutase (E.C.2.7.5.1, PGM), and pyruvate kinase
(E.C.2.7.1.40, PK).
Data analysis. The distance that each reproducible enzyme
band migrated from the origin (anode) was measured. The
bands were numerated from the fastest (the nearest one to
the cathode) to the slowest for each enzyme gel or zymogram.
The obtained set of bands defined an electrophoretic profile
for each extract. Stocks with the same profile were grouped in
the same zymodeme2; the species attribution was made com-
paring the profiles with the WHO reference Leishmania
strains. To examine the relationship between the zymodemes,
Jaccard distances (JD) were obtained for all pairwise com-
parisons,15 a distance matrix was built and transformed into a
phenogram by the unweighted pair group method using the
MEGA version 2.1 Software.16
RESULTS
Fourteen stocks, included the isolate from the dog were
assigned by MLEE analysis of 12 enzymatic loci to L. (V.)
braziliensis and two to L. (V.) guyanensis (Table 1; Figure
2A). No L. (L.) amazonensis was isolated from any patient.
For the L. (V.) braziliensis stocks, the isolates from humans
were grouped in 2 zymodemes, KMS 1 and KMS 2, differing
in 1 locus, MDH (Figure 2B). The stock from the dog was
assigned to another zymodeme, KMS 3 that differed from
KMS 1 only in 1 locus, ME (Figure 2C), and from KMS 2 in
2 loci, ME and MDH (Figures 2B and 2C).
Both L. (V.) guyanensis isolates were grouped in the same
zymodeme, KMS 4, that included the reference strain. Two
loci, G6PDH and 6GPDH, distanced them from the L. (V.)
panamensis reference strain. The enzymatic profiles are
shown in Table 2. The relationship between the zymodemes is
shown in a phenogram (Figure 3). Over a JD of 0.9, 2 clusters,
corresponding to the subgenera Viannia and Leishmania, can
be distinguished. The zymodemes KMS 1 and KMS 2 were
more closely related with each other (JD  0.056) than with
KMS 3 (JD  0.126) and with L. (V.) braziliensis reference
strains (JD  0.161). The JD observed between KMS 4 and
L. (V.) panamensis reference strains was 0.222.
In three different cases of the current study, two stocks
each were isolated from the same patient (MHOM/AR/02/
MAS5, MHOM/AR/03/MRO2, and MHOM/AR/03/HNO3);
they expressed the same enzymatic profile for each pair, with-
out demonstrating the possibility of co-infection with multiple
zymodemes and/or species of Leishmania parasite (Table 1;
Figure 3).
DISCUSSION
Leishmania species identification is essential for clinical or
epidemiologic surveys because of the diversity found among
FIGURE 2. A, 6-Phosphogluconate dehydrogenase (6PGDH) zymogram. Lanes 1 and 12, KMS 4; Lane 2, KMS 3; Lanes 3 and 4, KMS 1; Lane
5, KMS 2; Lane 6, Leishmania (Leishmania) mexicana ref. strain; Lane 7, L. (L.) amazonensis ref. strain; Lane 8, L. (Viannia) braziliensis ref.
strain; Lane 9, L. (V.) panamensis ref. strain; Lane 10, L. (V.) guyanensis ref. strain, and Lane 11, L. (L.) chagasi ref. strain. B, Malate
dehydrogenase (MDH) zymogram. Lane 1, KMS 3; Lanes 2, 3, and 4, KMS 1; and Lanes 5 and 6, KMS 2. C, Malic enzyme (ME) zymogram. Lane
1, KMS 3; Lanes 2 and 3, KMS 1; Lane 4, KMS 2; Lane 5, L. (L.) mexicana ref. strain; Lane 6, L. (L.) amazonensis ref. strain; Lane 7, L. (V.)
braziliensis ref. strain; Lane 8, L. (V.) panamensis ref. strain; Lane 9, L. (V.) guyanensis ref. Strain; and Lane 10, L. (L.) chagasi ref. strain.
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this genus.3 In this work, L (V.) braziliensis was incriminated
as a causative agent of three different clinical forms of ATL,
viz., CL, MCL, and RCL (recurrent cutaneous leishmaniasis)
and involved in failure of treatment with pentavalent anti-
mony drug. Leishmania (V.) braziliensis was the predominant
species in Salta Province, concordant with previous studies in
which the samples were taken mainly from CL cases.8,9
Although many factors are responsible for the clinical ex-
pression of Leishmania infection,17 it has recently been re-
ported that intraspecific polymorphism in L. (V.) braziliensis
species may be related to specific clinical forms of ATL.18 In
the current study, both of the L. (V.) braziliensis zymodemes,
KMS 1 and KMS 2, were found to have an ability to metas-
tasize to mucocutaneous tissues and lymph nodes. However,
we could not exclude the possibility that they have a tropism
for different tissues, such as mucosa or skin and lymph nodes.
Again, the main zymodeme, KMS 1, was isolated from both
MCL and CL cases; the other zymodeme, KMS 2, is con-
formed for isolates that are able to infect the lymph node and
induce recurrent cutaneous lesions far from the original scar.
Leishmania (V.) guyanensis (zymodeme KMS 4) was iso-
lated from patients with CL in two different geographic re-
gions, Salta in the northwest and Corrientes in the northeast
of Argentina. The same zymodeme grouped these stocks and
WHO reference strain, confirming the homogeneity previ-
ously reported for this species in other areas of different
countries.2,19 The current result confirms the presence of this
species in Argentina, which was reported for the first time in
1987 from a patient in the same endemic area, Orán, Salta.2
Recently, it has been proposed that L. (V.) guyanensis and
FIGURE 3. Relationship among 16 Argentinian Leishmania stocks from 12 patients (MAS5a, MAS5b, MRO2a, MRO2b, OLO1, RLS6, AZ3,
AAS4, NSS3, HNO3a, HNO3b, FDO4, CFO5, JDM1, and LBC1; a, b mean different isolates from the same patient), a dog (LPO1), and WHO
reference strains (M2904, LS94, M4147, M2682, M379, and M2269). The phenogram was built by the UPGMA method from the Jaccard distances
calculated.
TABLE 2
Enzymatic profiles for Argentinian stocks and WHO reference strain zymodemes
Zymodeme
Enzymatic loci
ALAT ASAT G6PDH 6GPDH GPI MDH ME MPI NHi1 NHi2 PGM PK
KMS 1 4 2 2 3 1,2 1,4,5 3 3,4,5 1 2 2 2
KMS 2 4 2 2 3 1,2 1,2,4,5 3 3,4,5 1 2 2 2
KMS 3 4 2 2 3 1,2 1,4,5 2 3,4,5 1 2 2 2
KMS 4 3 1 1 2 1,2 1,6 3 4,5,6 2 1 3 1
KMS 5 1 3 3 1 4 2,5 1 1 2 3 1 3
KMS 6 2 4 2 1 3 4 1 1 2 – 2 3
KMS 7 4 2 2 3 1,2 2,5 3 3,4,5 1 2 2 2
KMS 8 3 1 2 4 1,2 1,6 3 4,5,6 2 1 3 1
KMS 9 2 3 3 1 3 3 2 2 2 – 3 2
ALAT  alanine aminotransferase; ASAT  aspartate aminotransferase; G6PDH  glucose-6-phosphate dehydrogenase, 6GPDH  6-phosphogluconate dehydrogenase; GPI  glucose-
phosphate isomerase; MDH  malate dehydrogenase, ME  malic enzyme, MPI  mannose-phosphate isomerase; NHi1 and NHi2  nucleoside hydrolase (inosine); PGM  phosphoglu-
comutase; PK  pyruvate kinase; KMS  Kochi Medical School. KMS 1 (MHOM/AR/99/AZ3, MHOM/AR/02/NSS3, MHOM/AR/02/RLS6, MHOM/AR/02/MAS5 a and b, MHOM/AR/03/
AAS4, MHOM/AR/03/OLO1, and MHOM/AR/03/MRO2 a and b in Table 1), KMS 2 (MHOM/AR/03/HNO3 a and b, MHOM/AR/03/FDO4, and MHOM/AR/03/CFO5) and KMS 3
(MCAN/AR/02/LPO1) correspond to Leishmania (Viannia) braziliensis from Argentina. KMS 4: L. (V.) guyanensis ref. strain and two current stocks (MHOM/AR/98/LBC1 and MHOM/AR/
99/JDM1); KMS 5: L. (Leishmania) mexicana ref. strain; KMS 6: L. (L.) amazonensis ref. strain; KMS 7; L. (V.) braziliensis ref. strain; KMS 8: L. (V.) panamensis ref. strain; KMS 9: L. (L.)
chagasi (syn. infantum) ref. strain.
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L. (V.) panamensis should be considered as a unique clade
based on the discrete typing unit concept.15 In this study, only
two loci showed different characters between them, reaching
a relatively small degree of distance (JD  0.222). Such a
difference may not be enough to separate them as distinct
species. Nevertheless, the factors that control the species di-
versity within the genus Leishmania remain unknown. A bet-
ter understanding of taxonomic units for Leishmania will
come when we understand what controls their distribution.20
In a previous study of 208 dogs examined, 41 (19.7%) pre-
sented leishmanial lesions, and 14 (45.2%) out of 31 lesions
studied intensively were positive for Leishmania amastigotes,
but no parasite isolation in vitro was possible.11 In this work,
therefore, we are reporting for the first time the isolation and
characterization of Leishmania from dogs. Although the spe-
cies involved was L. (V.) braziliensis, its zymodeme was not
expressed by any of the isolates from humans. To incriminate
a reservoir host, the parasites isolated from the reservoirs
must be indistinguishable from those of man.4 This becomes
especially important in the case of clades of parasites, such as
L. (V.) braziliensis, in which their heterogeneity and plasticity
have been demonstrated.17,19,20 Although more isolates from
dogs need to be analyzed, this observation adds a point of
discussion on whether the animal has a principal role as a
reservoir of this disease, even when its prevalence is relatively
high in the endemic area. In Minas Gerais State, Brazil, an
intraspecific variation among L. (V.) braziliensis from dogs
was described.21 On the other hand, in Três Braços, Brazil,
two stocks isolated from dogs were shown to be indistinguish-
able from 15 isolates from humans by isoenzyme profiles.22
Furthermore, although L. (V.) braziliensis was found infect-
ing dogs and other domestic animals in the endemic areas of
different countries, the stocks characterization had reached,
analyzing a limited number of enzymes.23,24 Under these cir-
cumstances, a generalization about the indistinguishableness
among L. (V.) braziliensis isolated from humans and dogs
cannot be done as has been suggested.25 Therefore, in the
future, it should be proved in each study area, examining
enough materials (human and dog isolates) by suitable tech-
niques for the analysis.
The geographic origin of the zymodemes in the current
study suggests that both phytogeographical areas, Selva de
Transición and Chaco Occidental, are possible transmission
places for Leishmania (V.) spp. in Salta Province. Particularly
the same zymodeme of L. (V.) braziliensis, KMS 1, was found
in both zones. Considering the zoonotic characteristic of
ATL, this fact triggers questions such as if the same transmis-
sion cycle exists in both areas, is it related to the mobility and
the ability of the reservoirs to colonize different environment.
Therefore, a better understanding of the disease will be ob-
tained when the transmission cycles have been disclosed in
the areas.
Thus, the current data on the zymodemes from humans and
dogs will give important information on the causative agents
circulating in and around the endemic areas. By performing
further analysis using more stocks from humans, it would be
possible to disclose the relationships between the clinical fea-
tures and the zymodeme patterns in the country.
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